Antitumor responses stimulated by dendritic cells are improved by triiodothyronine binding to the thyroid hormone receptor β

Bidirectional cross-talk between the neuroendocrine and immune systems orchestrates immune responses in both physiologic and pathologic settings. In this study, we provide in vivo evidence of a critical role for the thyroid hormone triiodothyronine (T3) in controlling the maturation and antitumor fu...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado: 2015
Materias:
Acceso en línea:https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00085472_v75_n7_p1265_Alamino
http://hdl.handle.net/20.500.12110/paper_00085472_v75_n7_p1265_Alamino
Aporte de:
id paper:paper_00085472_v75_n7_p1265_Alamino
record_format dspace
spelling paper:paper_00085472_v75_n7_p1265_Alamino2023-06-08T14:32:08Z Antitumor responses stimulated by dendritic cells are improved by triiodothyronine binding to the thyroid hormone receptor β cytokine gamma interferon liothyronine thyroid hormone thyroid hormone receptor beta liothyronine thyroid hormone receptor beta animal cell animal experiment animal model antigen presenting cell antigen specificity Article cancer immunotherapy CD8+ T lymphocyte cell migration cell viability controlled study cytokine production cytotoxic T lymphocyte dendritic cell female immune response in vivo study innate immunity lymph node melanoma mouse nonhuman priority journal receptor binding T lymphocyte tumor growth animal C57BL mouse cell motion cell survival cross presentation cytotoxicity dendritic cell immunology immunotherapy Melanoma, Experimental metabolism transgenic mouse Animals CD8-Positive T-Lymphocytes Cell Movement Cell Survival Cross-Priming Cytotoxicity, Immunologic Dendritic Cells Female Immunotherapy Lymph Nodes Melanoma, Experimental Mice, Inbred C57BL Mice, Transgenic Thyroid Hormone Receptors beta Triiodothyronine Bidirectional cross-talk between the neuroendocrine and immune systems orchestrates immune responses in both physiologic and pathologic settings. In this study, we provide in vivo evidence of a critical role for the thyroid hormone triiodothyronine (T3) in controlling the maturation and antitumor functions of dendritic cells (DC). We used a thyroid hormone receptor (TR) β mutant mouse (TRβPV) to establish the relevance of the T3-TRβ system in vivo. In this model, TRβ signaling endowed DCs with the ability to stimulate antigen-specific cytotoxic T-cell responses during tumor development. T3 binding to TRβ increased DC viability and augmented DC migration to lymph nodes. Moreover, T3 stimulated the ability of DCs to cross-present antigens and to stimulate cytotoxic T-cell responses. In a B16-OVA mouse model of melanoma, vaccination with T3-stimulated DCs inhibited tumor growth and prolonged host survival, in part by promoting the generation of IFNγ-producing CD8+ T cells. Overall, our results establish an adjuvant effect of T3-TRβ signaling in DCs, suggesting an immediately translatable method to empower DC vaccination approaches for cancer immunotherapy. ©2015 AACR. 2015 https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00085472_v75_n7_p1265_Alamino http://hdl.handle.net/20.500.12110/paper_00085472_v75_n7_p1265_Alamino
institution Universidad de Buenos Aires
institution_str I-28
repository_str R-134
collection Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic cytokine
gamma interferon
liothyronine
thyroid hormone
thyroid hormone receptor beta
liothyronine
thyroid hormone receptor beta
animal cell
animal experiment
animal model
antigen presenting cell
antigen specificity
Article
cancer immunotherapy
CD8+ T lymphocyte
cell migration
cell viability
controlled study
cytokine production
cytotoxic T lymphocyte
dendritic cell
female
immune response
in vivo study
innate immunity
lymph node
melanoma
mouse
nonhuman
priority journal
receptor binding
T lymphocyte
tumor growth
animal
C57BL mouse
cell motion
cell survival
cross presentation
cytotoxicity
dendritic cell
immunology
immunotherapy
Melanoma, Experimental
metabolism
transgenic mouse
Animals
CD8-Positive T-Lymphocytes
Cell Movement
Cell Survival
Cross-Priming
Cytotoxicity, Immunologic
Dendritic Cells
Female
Immunotherapy
Lymph Nodes
Melanoma, Experimental
Mice, Inbred C57BL
Mice, Transgenic
Thyroid Hormone Receptors beta
Triiodothyronine
spellingShingle cytokine
gamma interferon
liothyronine
thyroid hormone
thyroid hormone receptor beta
liothyronine
thyroid hormone receptor beta
animal cell
animal experiment
animal model
antigen presenting cell
antigen specificity
Article
cancer immunotherapy
CD8+ T lymphocyte
cell migration
cell viability
controlled study
cytokine production
cytotoxic T lymphocyte
dendritic cell
female
immune response
in vivo study
innate immunity
lymph node
melanoma
mouse
nonhuman
priority journal
receptor binding
T lymphocyte
tumor growth
animal
C57BL mouse
cell motion
cell survival
cross presentation
cytotoxicity
dendritic cell
immunology
immunotherapy
Melanoma, Experimental
metabolism
transgenic mouse
Animals
CD8-Positive T-Lymphocytes
Cell Movement
Cell Survival
Cross-Priming
Cytotoxicity, Immunologic
Dendritic Cells
Female
Immunotherapy
Lymph Nodes
Melanoma, Experimental
Mice, Inbred C57BL
Mice, Transgenic
Thyroid Hormone Receptors beta
Triiodothyronine
Antitumor responses stimulated by dendritic cells are improved by triiodothyronine binding to the thyroid hormone receptor β
topic_facet cytokine
gamma interferon
liothyronine
thyroid hormone
thyroid hormone receptor beta
liothyronine
thyroid hormone receptor beta
animal cell
animal experiment
animal model
antigen presenting cell
antigen specificity
Article
cancer immunotherapy
CD8+ T lymphocyte
cell migration
cell viability
controlled study
cytokine production
cytotoxic T lymphocyte
dendritic cell
female
immune response
in vivo study
innate immunity
lymph node
melanoma
mouse
nonhuman
priority journal
receptor binding
T lymphocyte
tumor growth
animal
C57BL mouse
cell motion
cell survival
cross presentation
cytotoxicity
dendritic cell
immunology
immunotherapy
Melanoma, Experimental
metabolism
transgenic mouse
Animals
CD8-Positive T-Lymphocytes
Cell Movement
Cell Survival
Cross-Priming
Cytotoxicity, Immunologic
Dendritic Cells
Female
Immunotherapy
Lymph Nodes
Melanoma, Experimental
Mice, Inbred C57BL
Mice, Transgenic
Thyroid Hormone Receptors beta
Triiodothyronine
description Bidirectional cross-talk between the neuroendocrine and immune systems orchestrates immune responses in both physiologic and pathologic settings. In this study, we provide in vivo evidence of a critical role for the thyroid hormone triiodothyronine (T3) in controlling the maturation and antitumor functions of dendritic cells (DC). We used a thyroid hormone receptor (TR) β mutant mouse (TRβPV) to establish the relevance of the T3-TRβ system in vivo. In this model, TRβ signaling endowed DCs with the ability to stimulate antigen-specific cytotoxic T-cell responses during tumor development. T3 binding to TRβ increased DC viability and augmented DC migration to lymph nodes. Moreover, T3 stimulated the ability of DCs to cross-present antigens and to stimulate cytotoxic T-cell responses. In a B16-OVA mouse model of melanoma, vaccination with T3-stimulated DCs inhibited tumor growth and prolonged host survival, in part by promoting the generation of IFNγ-producing CD8+ T cells. Overall, our results establish an adjuvant effect of T3-TRβ signaling in DCs, suggesting an immediately translatable method to empower DC vaccination approaches for cancer immunotherapy. ©2015 AACR.
title Antitumor responses stimulated by dendritic cells are improved by triiodothyronine binding to the thyroid hormone receptor β
title_short Antitumor responses stimulated by dendritic cells are improved by triiodothyronine binding to the thyroid hormone receptor β
title_full Antitumor responses stimulated by dendritic cells are improved by triiodothyronine binding to the thyroid hormone receptor β
title_fullStr Antitumor responses stimulated by dendritic cells are improved by triiodothyronine binding to the thyroid hormone receptor β
title_full_unstemmed Antitumor responses stimulated by dendritic cells are improved by triiodothyronine binding to the thyroid hormone receptor β
title_sort antitumor responses stimulated by dendritic cells are improved by triiodothyronine binding to the thyroid hormone receptor β
publishDate 2015
url https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00085472_v75_n7_p1265_Alamino
http://hdl.handle.net/20.500.12110/paper_00085472_v75_n7_p1265_Alamino
_version_ 1768542719145148416